Evidence map›Paper›PMID 38102142›Full record

ArticleNature communications2023

Orphan quality control by an SCF ubiquitin ligase directed to pervasive C-degrons.

Ka-Yiu Edwin Kong, Susmitha Shankar, Frank Rühle, Anton Khmelinskii

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Degrons: defining the rules of protein degradation.Nature reviews. Molecular cell biology · 2025
    Review
  5. PEX1The Journal of biological chemistry · 2025
    Article
  6. Article
  7. N-degron pathways.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ka-Yiu Edwin Kong *Institute of Molecular Biology (IMB), Mainz, Germany. k.kong@imb-mainz.de.ORCID 0000-0001-8681-3237
Susmitha Shankar *Institute of Molecular Biology (IMB), Mainz, Germany.ORCID 0000-0002-3109-3911
Frank RühleInstitute of Molecular Biology (IMB), Mainz, Germany.ORCID 0000-0001-7688-2394
Anton KhmelinskiiInstitute of Molecular Biology (IMB), Mainz, Germany. a.khmelinskii@imb-mainz.de.ORCID 0000-0002-0256-5190

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 329045328Deutsche Forschungsgemeinschaft (German Research Foundation) P#210144599Deutsche Forschungsgemeinschaft (German Research Foundation) P#210253511EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) ERC- 2017-STG#759427
6 · The paper itself

Abstract

Selective protein degradation typically involves substrate recognition via short linear motifs known as degrons. Various degrons can be found at protein termini from bacteria to mammals. While N-degrons have been extensively studied, our understanding of C-degrons is still limited. Towards a comprehensive understanding of eukaryotic C-degron pathways, here we perform an unbiased survey of C-degrons in budding yeast. We identify over 5000 potential C-degrons by stability profiling of random peptide libraries and of the yeast C‑terminome. Combining machine learning, high-throughput mutagenesis and genetic screens reveals that the SCF ubiquitin ligase targets ~40% of degrons using a single F-box substrate receptor Das1. Although sequence-specific, Das1 is highly promiscuous, recognizing a variety of C-degron motifs. By screening for full-length substrates, we implicate SCF

Indexed as

DegronsSKP Cullin F-Box Protein LigasesAnimalsMammalsProtein DomainsProteolysisSaccharomyces cerevisiaeUbiquitin-Protein LigasesSKP Cullin F-Box Protein LigasesUbiquitin-Protein Ligases

Identifiers

PMID38102142
PMCPMC10724198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.